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ABSTRACT
Objectives: To determine the risk factors associated with
chlamydial infection in pregnancy and the sensitivity and
specificity of these when used for selective screening.
Methods: A prospective, cross-sectional study of
pregnant women aged 16–25 years attending four major
public antenatal services across Melbourne, Australia.
Between October 2006 and July 2007, women were
approached consecutively and asked to complete a
questionnaire and to provide a first-pass urine specimen
for Chlamydia trachomatis testing using PCR.
Results: Of 1180 eligible women, 1087 were approached
and 1044 (88%) consented to participate. Among the 987
women for whom a questionnaire and a definitive
diagnostic assay were available, the prevalence of
chlamydia was 3.2% (95% CI 1.8 to 5.9). In a multiple
logistic regression model, more than one sexual partner in
the past year (AOR 11.5; 95% CI 7.1 to 18.5) was
associated with chlamydia infection. The use of any
antibiotic within 3 months (AOR 0.2; 95% CI 0.1 to 0.6)
was associated with a decreased risk of infection.
Screening restricted to women who reported more than
one sexual partner in the past year would have detected
44% of infections in women aged 16–25 years and would
have required only 7% of women to be screened. The
addition of those women aged 20 years and under would
have required 27% of women to be screened and
detection of 72% of infections.
Conclusions: Selective chlamydia screening of pregnant
women based on risk factors can improve the yield from
screening. However, the potential harm of missed
infections among excluded women would need to be
considered.
Targeted screening of younger women for genital
Chlamydia trachomatis infection has been shown to
reduce the incidence of pelvic inflammatory disease
and has been advocated as a means of preventing
chlamydia-associated reproductive sequelae such as
infertility, ectopic pregnancy and chronic pelvic
pain.1–5 Although such screening and treatment has
been focussed on preventing reproductive pathol-
ogy and improving future fertility, chlamydial
infection in pregnancy is also associated with
adverse pregnancy outcomes and significant neo-
natal morbidity. For example, untreated chlamydia
infection in pregnancy increases a woman’s risk of
miscarriage, preterm prelabour rupture of mem-
branes, preterm labour and postpartum endome-
tritis, while babies born to mothers with
chlamydia are more likely to be of low birth
weight and are at risk of vertical transmission of
chlamydia leading to neonatal conjunctivitis and
pneumonitis.6–12
The US Preventive Services Task Force has found
evidence from observational studies that pregnant
women who are treated for chlamydia have
improved pregnancy and birth outcomes.
Accordingly, the Task Force recommends chlamy-
dia screening of all pregnant women aged 24 years
and younger, as well as older pregnant women
who are at increased risk for infection.4
However, there are limited published data from
larger, prospective studies from developed coun-
tries on the risk factors for chlamydia in pregnancy.
Such data would help to inform the development
of guidelines for the selective screening of pregnant
women for chlamydia. The aims of this study were
to determine the risk factors for chlamydia among
a broad cross-section of pregnant women in
Australia and to determine the sensitivity and
specificity of these risk factors when used as
criteria for selective chlamydia screening.
METHODS
Recruitment for this study was undertaken at four
major antenatal services across Melbourne,
Australia, between October 2006 and July 2007:
the Royal Women’s Hospital (Inner Northern
Melbourne), Mercy Hospital for Women (North
East Melbourne), Sunshine Hospital (Western
Melbourne) and Southern Health (South Eastern
Melbourne). The last service comprised clinics at
three separate sites: the Monash Medical Centre,
Dandenong Hospital and Casey Hospital. Multiple
sites were selected to include women from across a
wide geographic area as well as diverse socio-
economic and cultural backgrounds.
Eligible women were pregnant of any gestation,
aged 16–25 years, attending any of the four
antenatal services. Recruitment was restricted to
this age group to minimise the likelihood of false-
positive chlamydia results, which would be higher
among older women where the prevalence of
infection would be expected to be lower. This
was also in line with national and international
guidelines.4 5 13 At the time of the study, screening
for chlamydia across this age group was not
routinely offered at the participating services.
Women aged 16–25 years were approached
consecutively as they arrived at the clinic. They
were provided with a participant information sheet
explaining the study and a consent form. The total
number of women aged 16–25 years attending the
clinics while recruitment was being undertaken
was noted.
Women who consented to the study were asked to
complete an anonymous questionnaire and to
provide a first-pass urine sample. The questionnaire
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included questions about demographics, genitourinary symp-
toms, recent sexual history and the self-reported use of any
antibiotics within the preceding 3 months. Women were also
asked to report how likely they thought it was that they or any
sexual partner in the past year could be infected with
chlamydia.
Translations of the questionnaire were printed in Chinese,
Arabic and Vietnamese. Interpreters were available for a number
of other languages and were used if a woman felt comfortable
with and consented to completing the English version of the
questionnaire with the interpreter. All other women completed
the questionnaire unassisted in a private room and returned the
questionnaire in a sealed envelope. People accompanying the
women to the clinic were asked to wait outside whilst the
participant completed the questionnaire. Women were excluded
if they were not able to complete the questionnaire because an
interpreter was not available for their preferred language.
First-pass urine specimens were tested for C trachomatis by
PCR using the COBAS Amplicor Assay (Roche Diagnostics,
Pleasanton, California, USA) as described by the manufacturer.
Specimens showing inhibition were retested using another
specimen collected at a subsequent visit.
Infected women were treated with single-dose oral azithro-
mycin (1.0 g) and were asked to provide a repeat urine sample at
a subsequent visit at least 3 weeks after treatment. Women
were advised to contact their sexual partner(s) so that they
could seek testing and treatment for chlamydia. We did not aim
to determine pregnancy or neonatal outcomes so data on these
were not collected.
The prevalence of genital chlamydia was calculated, with the
standard errors and associated 95% CIs adjusted for the
possibility of residual correlation in the outcome measure due
to clustering of participants at the hospital level. Associations
between questionnaire variables and chlamydia infection were
investigated using multiple logistic regression with odds ratios
(ORs) and 95% CIs. A stepwise technique was used for model
selection, with variables selected for inclusion in the model if
the likelihood ratio test for model comparison generated p,0.1
The sensitivity of a risk factor for detecting chlamydia was
defined as the probability of the risk factor being present among
infected women, and represents the proportion of infected
women who would be detected by screening using that risk
factor. The specificity of a risk factor for detecting chlamydia
was defined as the probability of the risk factor being absent
among uninfected women, and represents the proportion of
uninfected women who would avoid screening if it was based
on that risk factor. All analyses were conducted in Stata V.9
(StataCorporation 2005, Stata Statistical Software, Release 9.0,
College Station, Texas, USA).
RESULTS
During the recruitment period, 1180 eligible women attended
the antenatal clinics while recruitment was taking place. Of
these women, 1087 (92%) were invited to participate and 1044
(88% of those eligible) consented to participate in the study.
Altogether, 1009 women provided both a completed question-
naire and a urine sample for chlamydia testing.
In 22 women (2.2% of those tested), the result of chlamydia
testing remained indeterminate despite repeat specimen collec-
tion and testing. All further analyses were undertaken on the
987 women for whom definitive results were available.
Among these 987 women, 32 women tested positive for
chlamydia giving a prevalence rate of 3.2% (95% CI 1.8 to 5.9).
The prevalence was similar among three of the hospital services
(Royal Women’s: 2.0%; 95% CI 0.6 to 4.5; Mercy Hospital for
Women: 2.0%; 95% CI 0.6 to 6; and Sunshine Hospital: 2.9%;
95% CI 1.2 to 5.9), but was significantly higher at one of the
services (Southern Health: 6.3%; 95% CI 3.6 to 10.1; p,0.01).
Women attending Southern Health were on average 6 months
younger than those attending the other hospitals (p,0.01) and
had a higher number of recent sexual partners (p,0.01). These
two factors contributed to the higher chlamydia prevalence
observed at this hospital.
Women in the study were culturally and linguistically diverse
(table 1) and were drawn from 171 different postal areas across
Victoria. Only 6.6% (65/987) of women reported having more
than one sexual partner during the past year. There was no
relationship between self-reporting of risk perception and
infection status (table 2). Self-reported symptoms (vaginal
discharge, dysuria) were not informative of infection status
(table 2).
Thirty-one of the infected women received treatment, with
one unable to be contacted. Twenty-five women provided a
repeat chlamydia test following treatment, all of which were
negative for C trachomatis. Data were not collected on the
testing or treatment of partners, or on when repeat tests in
infected women were performed. The characteristics of women
with and without chlamydia are compared in table 2.
Univariate analysis found that chlamydia infection was
associated with being born outside Australia, not speaking a
Table 1 Characteristics of pregnant women screened for chlamydia
Variables
Median (range)
or n (%)*
Age in years (range) 23 (16–25)
Country of birth
Australia 568 (57.5)
Other{ 419 (42.5)
Preferred language other than English
No 800 (81.1)
Yes{ 187 (18.9)
Socio-economic indexes for areas"
1 241 (24.4)
2 147 (14.9)
2,3 108 (10.9)
3 175 (17.7)
4 95 (9.6)
Number of prior births
0 660 (66.9)
1 252 (25.5)
.1 73 (7.4)
Self-report of prior chlamydia testing
Yes 131 (13.3)
No 708 (71.7)
Unsure 141 (14.4)
Months since last chlamydia test (range)1 18 (1–96)
Gestation in weeks (range) 27 (5–42)
No. of male sexual partners in past year (range) 1 (0–50)
*The total numbers may not equal 987 because of missing data; {19% were born in
Asia, 6.7% in Africa, 5.2% in Europe, 5.1% in the Middle East, 3.7% in New Zealand
and 1.4% in the Pacific; 2% were identified as Aboriginal or Torres Strait Islander;
{preferred languages other than English included Arabic (3%), languages from Sudan
and the horn of Africa (3%), Vietnamese (2.5%), Indian languages (2.2%), Chinese
languages (1.7%), Urdu (1.3%), Dari (0.6%), Khmer (0.6%), Macedonian (0.5%) and
Turkish (0.5%); "Socio-Economic Indexes for Areas (SEIFA) indicate a continuum of
advantage (high values) to disadvantage (low values) and have been allocated based
on postal area of residence. The index takes into account variables such as income,
education and employment. Some postal areas cross-multiple SEIFA areas: only the
most frequent combinations have been listed; 1self-reported estimate from the 131
women who reported prior chlamydia testing.
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language other than English, unplanned pregnancy, a new sexual
partner in the past year, reporting more than one sexual partner in
the past year and not being in a current relationship. Multiple
logistic regression found that having more than one sexual partner
in the past year and not having preferred language other than
English remained associated with increased risk for chlamydia,
while antibiotic use in the past 3 months was associated with
decreased risk of infection (table 2) after adjusting for other factors.
Country of birth and educational level were each strongly
correlated with language spoken at home (p,0.01); language
Table 2 Characteristics associated with chlamydia infection among pregnant women
Characteristic No. women* No. infected % infected
Unadjusted OR
(95% CI)
Adjusted OR{
(95% CI) p Value
Age group (years)
16–20 234 15 6.4 3.0 (0.8 to 0.7) 2.1 (0.6 to 7.9) 0.25
21–25 753 17 2.3 1.0 1.0
Country of birth
Australia 568 22 2.4 0.6 (0.4 to 0.9) –
Other 419 10 3.9 1.0 –
Preferred language
other than English
No 800 29 3.6 2.3 (1.2 to 4.4) 1.4 (0.9 to 2.3) 0.15
Yes 187 3 1.6 1.0 1.0
Educational level
Year 9 or less 102 5 4.9 1.0 –
Year 10–12 617 22 3.6 0.7 (0.4 to 1.2) –
Tertiary
qualification
268 5 1.9 0.4 (0.1 to 1.5) –
Planned pregnancy
No 498 25 5.0 1.0 –
Yes 487 7 1.4 0.3 (0.1 to 0.5) –
History of chlamydia
No 738 21 2.8 NA NA
Yes 51 0 0
Unsure 198 11 5.6
Antibiotics in past 3
months
No 809 30 3.7 1.0 1.0
Yes 175 2 1.1 0.3 (0.1 to 0.7) 0.2 (0.1 to 0.6) ,0.01
Vaginal discharge
No or unsure 820 27 3.3 1.0 –
Yes 162 5 3.1 0.9 (0.1 to 2.2) –
Dysuria
No or unsure 878 30 3.4 1.0 –
Yes 104 2 1.9 0.6 (0.1 to 2.4) –
Relationship status
Married or in a
relationship and
living with partner
801 21 2.6 1.0 –
In a relationship but
not livingwithpartner
132 7 5.3 2.1 (0.9 to 4.5) –
Not in a relationship 54 4 7.4 3.0 (1.1 to 7.8) –
New sexual partner in
past year
No 921 24 2.6 1.0 –
Yes 65 8 12.3 5.2 (2.7 to 10.3) –
No. of male sexual
partners in past year
(1 921 18 2.0 1.0 1.0
.1 66 14 21.2 13.5 (9.6 to 19.1) 11.5 (7.1 to
18.5)
,0.01
Self-perceived risk for
chlamydia
Unlikely 888 27 3.0 1.0 –
Possible or likely 94 5 5.3 1.8 (0.7 to 4.3) –
Perceived risk of
chlamydia in sexual
partner(s)
Unlikely 883 28 3.3 1.0 –
Possible or likely 104 4 3.8 1.2 (0.8 to 1.9) –
*The total numbers may not equal 987 because of missing data; {adjusted for age, language spoken at home, antibiotic use in last
3 months and number of male sexual partners in past year. NA, not applicable.
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spoken at home was a stronger predictor of chlamydia infection
and retained in the model. Reporting a new sexual partner,
unplanned pregnancy and relationship status were each
strongly associated with the number of reported sexual partners
(p,0.01), but the number of sexual partners was a stronger
predictor of chlamydia infection and remained in the logistic
regression model. The prevalence of infection among women
reporting more than one sexual partner in the previous year was
21.2% (95% CI 12.1 to 33.0%)
The sensitivity and specificity of selected variables for the
detection of chlamydia in this population are shown in table 3.
Screening women solely on the basis of reporting more than one
sexual partner in the past year would have required only 7% of
women aged 16–25 years to be screened to detect 44% of
infections. By comparison, screening all women aged 20 years
and under would have required 24% of women aged 16–25 years
to be screened with little increase in the detection rate (47%).
Using a combination of both these risk factors would have
required 27% of women to be screened leading to the detection
of 72% of infections.
For age—the only continuously valued covariate—we gener-
ated a receiver operating characteristic curve to examine how
the sensitivity and specificity changed with the cut-off age for
screening. The estimated area under the curve (AUC) was 0.64
(95% CI 0.54 to 0.75)—an improvement on the null value of
AUC = 0.50 associated with random screening (p = 0.009).
DISCUSSION
In this study, a higher number of recent sexual partners was
predictive of chlamydia infection in pregnancy after adjusting
for other risk factors. If screening had been limited to women
who reported more than one partner in the past year, only 7%
of women would have required screening with 44% of
infections detected. The addition of women aged 20 years and
younger would have increased the detection rate to 72% with
27% of women screened. Even with the latter approach,
however, a proportion of infections would have escaped
detection.
This is one of the largest and most representative studies to
be published on the risk factors for chlamydia in pregnancy
from a developed country. Sampling of women for this study
was undertaken at multiple antenatal sites, capturing a diverse
group of women from across a wide geographical area. The
study was prospective, with consecutive women approached
and a very high participation rate.
It is uncertain to what extent the findings of this study
would apply to populations of pregnant women with differing
demographic and sexual risk profiles. Overall, the sexual risk
profile of women in this study was relatively low compared
with other cross-sectional studies of chlamydia in selected
female populations and comparable to that of the local, broader,
population of non-pregnant women of similar age. Altogether,
95% of women in this study reported only one sexual partner in
the past year the study. By comparison, in a national
representative survey, 33% of Australian women aged 16–19
and 15% of women aged 20–29 years had more than one male
partner in the past year.14 The factors associated with chlamydia
in this population and the performance of the criteria used for
selective screening may not be applicable in other populations.
Further validation of these criteria in other populations is
required. This was a cross-sectional study that did not examine
for possible re-infection during pregnancy or collect data on
whether sexual partners were treated. Furthermore, informa-
tion was not sought on maternal or neonatal outcomes
associated with chlamydia infection.
A number of previous studies have examined the prevalence
of and risk factors for chlamydia in various populations of
pregnant women in developed settings. However, the generali-
sability of some of these studies is limited by small sample sizes
and samples potentially biased towards women at higher risk
for infection, such as women seeking termination of pregnancy
or women from selected ethnic groups. Others have involved
retrospective review of medical records, where selection bias
may be a problem.15–18
Separate, larger studies of pregnant women from Hungary
(n = 6161), London (n = 1216) and Dublin (n = 783) each found
younger age to be a predictor of chlamydia infection after
adjusting for other factors. However, none of these other
studies assessed the women’s recent sexual risk nor did any
provide the participation rates for their study.19–21 In our study,
having more than one sexual partner in the past year was, in
fact, the strongest predictor of chlamydia infection and
remained so after adjustment for other factors, including age.
We are not aware of any other published studies that have
reported on the sensitivity and specificity of risk factor criteria
in the selective screening of pregnant women for chlamydia.
The sensitivity and specificity of risk factors for screening
pregnant women for gonorrhoea and chlamydia combined was
examined in a US study, but not for chlamydia alone.
Furthermore, data were not collected on recent sexual risk.22
In our study, screening was not restricted to any particular
gestational period. The US Centers for Disease Control and
Prevention (CDC) recommends chlamydia screening of preg-
nant women at the first antenatal visit, with retesting during
the third trimester in women aged less than 25 years and those
who have had either a new or more than one sexual partner.5 If
screening is restricted to early pregnancy, women can be re-
infected later on, prior to delivery. If screening only occurs late
in pregnancy, any obstetric infection associated sequelae, such
as preterm labour, may, hypothetically, not be averted,
although there is no empirical evidence to support this.5
Despite the likely benefits of screening younger pregnant
women for chlamydia,4 and recommendations for screening
pregnant women under the age of 25 years in some countries, in
practice the extent of screening within this group varies
considerably within and between countries.5 13 23 24 The findings
from this study indicate that selective chlamydia screening
based on risk factors for infection can substantially improve the
yield from screening. However, if screening based on risk factors
Table 3 Sensitivity and specificity of risk factors for predicting
chlamydia infection among pregnant women
Sensitivity
(95% CI)
Specificity
(95% CI)
Proportion
screened (%)
Age (20 years 47% (29 to 65%) 77% (74 to 80%) 24
Unplanned pregnancy 78% (60 to 91%) 50% (47 to 54%) 49
.1 sexual partner 44% (26 to 62%) 94% (93 to 96%) 7
New sexual partner in
past year
25% (11 to 43%) 94% (92 to 95%) 7
No antibiotic use in past 3
months
94% (79 to 99%) 18% (16 to 21%) 82
Age (20 years and/or
.1 partner in past year
72% (53 to 86%) 74% (71 to 77%) 27
.1 partner and/or new
sexual partner in past
year
47% (29 to 65%) 93% (90 to 94%) 9
Age (20 years and/or
unplanned pregnancy
59% (41 to 76%) 35% (32 to 38%) 65
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of selected women under the age of 25 years is considered,
rather than universal screening of all women in this age group,
the potential harm of missed infections needs to be considered.
Ideally, decisions on whether screening should be conducted,
and what criteria should be used, should take into account local
data on prevalence and risk factors together with the cost-
effectiveness of different approaches.
If an assessment of a woman’s sexual risk is used for selective
chlamydia screening, obstetricians, midwives and other provi-
ders of antenatal care will need to be comfortable asking about
recent sexual history. Given that most pregnant women
infected with chlamydia do not suspect that either they or
their sexual partners could be infected—as shown in this and
another study25—screening should not rely on a woman’s self-
perceived risk.
Future studies looking at the risk factors for chlamydia in
other populations of pregnant women should assess sexual risk
and ensure this is accounted for as a possible confounding
factor. So far, there have been no randomised trials comparing
the outcomes of chlamydia screening versus no screening in
pregnant women: one that compares routine, universal screen-
ing of young pregnant women with the existing standard of
care, which in many settings consists of either sporadic or
highly selective screening. Such a study would be ethical if
women in the control arm received the accepted standard of
care for that population. It is likely that a large, cluster
randomised study would be required to demonstrate any effect
given that chlamydia-associated maternal and neonatal out-
comes are relatively uncommon. Such a study, however, is
needed to help inform whether screening of pregnant women
should be widely implemented. If so, our study shows that high
screening rates within antenatal clinics are achievable.
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c The number of recent male sexual partners is associated with
chlamydia infection in pregnant women.
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